Home › Companies › PARATEK PHARMACEUTICALS INC. › 2023-2024
At PARATEK PHARMACEUTICALS INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held July 6, 2023 and September 18, 2023), 77 asset managers reported how they voted in their SEC Form N-PX filings, covering 532 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held September 18, 2023 — To approve, by a non-binding, advisory vote, certain compensation arrangements for the… — PARATEK PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 60% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PARATEK PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on September 18, 2023.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PARATEK PHARMACEUTICALS INC.’s Form 8-K, filed July 11, 2023 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of July 6, 2023: 7 items on PARATEK PHARMACEUTICALS INC.’s Form 8-K, filed July 11, 2023: 2 elected · 3 approved · 1 not approved · 1 without a stated outcome.
Meeting of September 18, 2023: 2 items on PARATEK PHARMACEUTICALS INC.’s Form 8-K, filed September 18, 2023: 2 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore PARATEK PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are PARATEK PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 11, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. PARATEK PHARMACEUTICALS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Minnie V. Baylor-Henry | 19,561,082 | -- | -- | 9,375,157 | 10,527,365 | 68% | Not verified | — |
| Elect Director: Michael F. Bigham | 19,421,744 | -- | -- | 9,514,495 | 10,527,365 | 67% | Elected | — |
| Elect Director: Robert S. Radie | 19,430,048 | -- | -- | 9,506,191 | 10,527,365 | 67% | Elected | — |
| 2. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers | 19,043,007 | 9,815,685 | 77,547 | -- | 10,527,365 | 66% | Approved | — |
| 4. Approval of the Amended and Restated Paratek Pharmaceuticals, Inc. Employee Stock Purchase Plan | 18,941,378 | 9,933,558 | 61,303 | -- | 10,527,365 | 66% | Approved | — |
| 5. Approval of an Amendment to the Company's Amended and Restated Certificate of Incorporation to Allow for Officer Exculpation | 17,201,102 | 11,532,973 | 202,164 | -- | 10,527,365 | 60% | Not approved A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it. | — |
| 6. Ratification of Selection of Independent Registered Public Accounting Firm | 38,200,538 | 972,021 | 291,045 | -- | -- | 98% | Approved | — |
Source: PARATEK PHARMACEUTICALS INC., Form 8-K, filed with the SEC on July 11, 2023 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Proposal to approve and adopt the Agreement and Plan of Merger, dated June 6, 2023 (the "Merger Agreement") by and among the Company, Resistance Acquisition, Inc., a Delaware corporation ("Parent"), and Resistance Merger Sub, Inc., a Delaware corporation (" | 31,250,056 | 9,912,755 | 173,682 | -- | -- | 76% | Approved | — |
| 2. Non-binding, advisory proposal to approve certain compensation arrangements for the Company's named executive officers in connection with the Merger (the "Management Compensation Proposal") | 24,648,845 | 16,379,806 | 307,842 | -- | -- | 60% | Approved | — |
Source: PARATEK PHARMACEUTICALS INC., Form 8-K, filed with the SEC on September 18, 2023 — read the filing on EDGAR.
Each item below shows how the 77 asset managers that disclosed a PARATEK PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PARATEK PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held July 6, 2023.
Combines 2 wordings of this item as funds reported it.
67% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael F. Bigham
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michael F. Bigham”): 19,421,744 for, 9,514,495 withheld, per its Form 8-K filed July 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final votes on the proposals presented at the meeting were as follows: Proposal No. 1 – Election of Directors Minnie V. Baylor-Henry, Michael F. Bigham and Robert S. Radie were elected as directors to hold office until the 2026 Annual Meeting of Stockholders and until their successors have been…”
Support: 67% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 21 asset managers below reported 5,684,227 for, 2,271,770 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 0 | 2,156,000 | 0 | Abstain |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 0 | 0 | 64,770 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 61,000 | 0 | 0 | 0 | For |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 0 | 50,000 | 0 | Abstain |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,271 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 15,971 | 0 | 0 | 0 | For |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 0 | 1,000 | 0 | Abstain |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 167 | 0 | 0 | 0 | For |
Meeting held July 6, 2023.
Combines 2 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Minnie V. Baylor-Henry
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Minnie V. Baylor-Henry”): 19,561,082 for, 9,375,157 withheld, per its Form 8-K filed July 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 21 asset managers below reported 5,684,227 for, 2,271,770 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 0 | 2,156,000 | 0 | Abstain |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 0 | 0 | 64,770 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 61,000 | 0 | 0 | 0 | For |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 0 | 50,000 | 0 | Abstain |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,271 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 15,971 | 0 | 0 | 0 | For |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 0 | 1,000 | 0 | Abstain |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 167 | 0 | 0 | 0 | For |
Meeting held July 6, 2023.
Combines 2 wordings of this item as funds reported it.
67% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Robert S. Radie
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Robert S. Radie”): 19,430,048 for, 9,506,191 withheld, per its Form 8-K filed July 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final votes on the proposals presented at the meeting were as follows: Proposal No. 1 – Election of Directors Minnie V. Baylor-Henry, Michael F. Bigham and Robert S. Radie were elected as directors to hold office until the 2026 Annual Meeting of Stockholders and until their successors have been…”
Support: 67% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 21 asset managers below reported 5,593,596 for, 90,631 withheld, 2,271,770 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 0 | 2,156,000 | 0 | Abstain |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 0 | 0 | 64,770 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 61,000 | Withhold |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 0 | 50,000 | 0 | Abstain |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,271 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 0 | 0 | 0 | 15,971 | Withhold |
| Northern Trust | 0 | 0 | 0 | 13,493 | Withhold |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 0 | 1,000 | 0 | Abstain |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 167 | Withhold |
Meeting held September 18, 2023.
Combines 4 wordings of this item as funds reported it.
76% Approved · of votes cast
Description as filed by funds: To approve and adopt the Agreement and Plan of Merger, dated June 6, 2023 (the "Merger Agreement") by and among Paratek Pharmaceuticals, Inc. (the "Company"), Resistance Acquisition, Inc., ("Parent"), and Resistance Merger Sub, Inc. ("Merger Subsidiary"), pursuant to which, among other things, Merger Subsidiary will merge with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, and the other transactions contemplated by Merger Agreement (the "Contemplated Transactions"), including the Merger.
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“1. Proposal to approve and adopt the Agreement and Plan of Merger, dated June 6, 2023 (the "Merger Agreement") by and among the Company, Resistance Acquisition, Inc., a Delaware corporation ("Parent"), and Resistance Mer”): 31,250,056 for, 9,912,755 against — passed, per its Form 8-K filed September 18, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 1: Proposal to approve and adopt the Agreement and Plan of Merger, dated June 6, 2023 (the "Merger Agreement") by and among the Company, Resistance Acquisition, Inc., a Delaware corporation ("Parent"), and Resistance Merger Sub, Inc., a Delaware corporation ("Merger Sub"), pursuant to whic…”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 5,223,176 for, 2,495,770 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 2,156,000 | 0 | 0 | Against |
| Vanguard | 1,528,599 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,461,129 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| Fidelity | 400,868 | 0 | 0 | 0 | For |
| BlackRock | 233,050 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 225,000 | 0 | 0 | Against |
| NEXPOINT FUNDS II | 0 | 64,770 | 0 | 0 | Against |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 50,000 | 0 | 0 | Against |
| Gabelli | 37,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 25,000 | 0 | 0 | 0 | For |
| AltShares Trust | 18,700 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,250 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 15,971 | 0 | 0 | 0 | For |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Equitable | 10,489 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 7,200 | 0 | 0 | 0 | For |
| Victory Capital | 4,924 | 0 | 0 | 0 | For |
| Comstock Funds, Inc. | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
Meeting held July 6, 2023.
Combines 3 wordings of this item as funds reported it.
60% Not approved · of votes cast
Description as filed by funds: To approve an amendment to the Company's Charter to allow for officer exculpation.
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“5. Approval of an Amendment to the Company's Amended and Restated Certificate of Incorporation to Allow for Officer Exculpation”): 17,201,102 for, 11,532,973 against — failed, per its Form 8-K filed July 11, 2023 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “Proposal No. 5 – Approval of an Amendment to the Company's Amended and Restated Certificate of Incorporation to Allow for Officer Exculpation The Company's stockholders rejected an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to allow for officer exculpa…”
A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it.
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 4,302,168 for, 3,749,829 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 2,156,000 | 0 | 0 | Against |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 0 | 1,427,412 | 0 | 0 | Against |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 0 | 64,770 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 61,000 | 0 | 0 | 0 | For |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 50,000 | 0 | 0 | Against |
| TETON WESTWOOD FUNDS | 33,000 | 0 | 0 | 0 | For |
| World Funds Trust | 32,000 | 0 | 0 | 0 | For |
| Gabelli | 31,000 | 0 | 0 | 0 | For |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 17,405 | 0 | 0 | Against |
| Amplify ETF Trust | 0 | 17,271 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 15,971 | 0 | 0 | Against |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 1,000 | 0 | 0 | Against |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 167 | 0 | 0 | 0 | For |
Meeting held September 18, 2023.
54.7% of fund votes cast · no official result
Description as filed by funds: To approve one or more adjournments of the Special Meeting if there are insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement.
The 13 asset managers below reported 3,008,297 for, 2,495,770 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 2,156,000 | 0 | 0 | Against |
| GENERAL AMERICAN INVESTORS CO INC | 1,461,129 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 225,000 | 0 | 0 | Against |
| NEXPOINT FUNDS II | 0 | 64,770 | 0 | 0 | Against |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 50,000 | 0 | 0 | Against |
| Gabelli | 37,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 25,000 | 0 | 0 | 0 | For |
| AltShares Trust | 18,700 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,250 | 0 | 0 | 0 | For |
| Comstock Funds, Inc. | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 901 | 0 | 0 | 0 | For |
Meeting held September 18, 2023.
82% of fund votes cast · no official result
Description as filed by funds: To approve one or more adjournments of the Special Meeting if there are insufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal.
The 9 asset managers below reported 1,820,011 for, 394,868 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,528,599 | 0 | 0 | 0 | For |
| Fidelity | 6,000 | 394,868 | 0 | 0 | Against |
| BlackRock | 233,050 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 15,971 | 0 | 0 | 0 | For |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Equitable | 10,489 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 7,200 | 0 | 0 | 0 | For |
| Victory Capital | 4,924 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
Meeting held July 6, 2023.
Combines 3 wordings of this item as funds reported it.
66% Approved · of votes cast
Description as filed by funds: To approve the Company's Amended and Restated Employee Stock Purchase Plan, which increases the number of authorized shares of common stock under the plan from 943,294 to 1,793,067 shares.
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“4. Approval of the Amended and Restated Paratek Pharmaceuticals, Inc. Employee Stock Purchase Plan”): 18,941,378 for, 9,933,558 against — passed, per its Form 8-K filed July 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 4 – Approval of the Amended and Restated Paratek Pharmaceuticals, Inc. Employee Stock Purchase Plan The Company's stockholders approved the amended and restated Paratek Pharmaceuticals, Inc. Employee Stock Purchase Plan by the following vote:”
Support: 66% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 5,780,227 for, 2,271,770 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 2,156,000 | 0 | 0 | Against |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 0 | 64,770 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 61,000 | 0 | 0 | 0 | For |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 50,000 | 0 | 0 | Against |
| TETON WESTWOOD FUNDS | 33,000 | 0 | 0 | 0 | For |
| World Funds Trust | 32,000 | 0 | 0 | 0 | For |
| Gabelli | 31,000 | 0 | 0 | 0 | For |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,271 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 15,971 | 0 | 0 | 0 | For |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 1,000 | 0 | 0 | Against |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 167 | 0 | 0 | 0 | For |
Meeting held September 18, 2023.
Combines 5 wordings of this item as funds reported it.
60% Approved · of votes cast
Description as filed by funds: To approve, by a non-binding, advisory vote, certain compensation arrangements for the Company's named executive officers in connection with the Merger.
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“2. Non-binding, advisory proposal to approve certain compensation arrangements for the Company's named executive officers in connection with the Merger (the "Management Compensation Proposal")”): 24,648,845 for, 16,379,806 against — passed, per its Form 8-K filed September 18, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Set forth below are the voting results for the Management Compensation Proposal, which was approved by the Company's stockholders on a non-binding, advisory basis:”
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 2,156,000 | 0 | 0 | Against |
| Vanguard | 1,504,199 | 24,400 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,461,129 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| Fidelity | 0 | 400,868 | 0 | 0 | Against |
| BlackRock | 0 | 233,050 | 0 | 0 | Against |
| NEXPOINT FUNDS I | 0 | 225,000 | 0 | 0 | Against |
| NEXPOINT FUNDS II | 0 | 64,770 | 0 | 0 | Against |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 50,000 | 0 | 0 | Against |
| Gabelli | 37,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 25,000 | 0 | 0 | 0 | For |
| AltShares Trust | 18,700 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 17,405 | 0 | 0 | Against |
| Amplify ETF Trust | 0 | 17,250 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 15,971 | 0 | 0 | Against |
| Northern Trust | 0 | 13,493 | 0 | 0 | Against |
| Equitable | 0 | 10,489 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 7,200 | 0 | 0 | Against |
| Victory Capital | 0 | 4,924 | 0 | 0 | Against |
| Comstock Funds, Inc. | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 0 | 901 | 0 | 0 | Against |
| Guggenheim | 0 | 285 | 0 | 0 | Against |
Fund voting reports, all 22 managers: 4,476,940 for, 3,242,006 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 1,734,036 | 0 | 0 | 0 | For |
| BlackRock | 0 | 641,189 | 0 | 0 | Against |
| Polar Asset Management Partners Inc. | 612,402 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 428,136 | 0 | 0 | Against |
| Verition Fund Management LLC | 0 | 423,409 | 0 | 0 | Against |
| Two Sigma | 0 | 367,966 | 0 | 0 | Against |
| Newtyn Management, LLC | 344,444 | 0 | 0 | 0 | For |
| BROWN BROTHERS HARRIMAN & CO | 0 | 287,902 | 0 | 0 | Against |
| DE Shaw | 0 | 247,643 | 0 | 0 | Against |
| State Street | 0 | 132,310 | 0 | 0 | Against |
| PenderFund Capital Management Ltd. | 113,590 | 0 | 0 | 0 | For |
| DELTEC ASSET MANAGEMENT LLC | 113,560 | 0 | 0 | 0 | For |
| WATER ISLAND CAPITAL LLC | 83,633 | 0 | 0 | 0 | For |
| Renaissance | 0 | 75,516 | 0 | 0 | Against |
| Yakira Capital Management, Inc. | 67,941 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 60,074 | 0 | 0 | Against |
| Deuterium Capital Management, LLC | 55,136 | 0 | 0 | 0 | For |
| Gabelli | 26,400 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 17,893 | 0 | 0 | Against |
| Charles Schwab | 0 | 17,405 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 16,610 | 0 | 0 | Against |
| Northern Trust | 0 | 16,332 | 0 | 0 | Against |
| Vanguard | 15,267 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 14,000 | 0 | 0 | Against |
| Black Maple Capital Management LP | 10,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 51 managers: 3,177,902 for, 2,781,194 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held July 6, 2023.
Combines 4 wordings of this item as funds reported it.
66% Approved · of votes cast
Description as filed by funds: TO CONSIDER AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“2. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers”): 19,043,007 for, 9,815,685 against — passed, per its Form 8-K filed July 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 – Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers, by the following vote:”
Support: 66% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 2,156,000 | 0 | 0 | Against |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 0 | 64,770 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 61,000 | 0 | 0 | 0 | For |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 50,000 | 0 | 0 | Against |
| TETON WESTWOOD FUNDS | 33,000 | 0 | 0 | 0 | For |
| World Funds Trust | 32,000 | 0 | 0 | 0 | For |
| Gabelli | 31,000 | 0 | 0 | 0 | For |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 17,271 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 15,971 | 0 | 0 | Against |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 0 | 1,000 | 0 | 0 | Against |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 0 | 167 | 0 | 0 | Against |
Fund voting reports, all 24 managers: 5,746,818 for, 2,305,179 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 1,675,251 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 1,353,394 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 588,685 | 0 | 0 | 0 | For |
| BROWN BROTHERS HARRIMAN & CO | 0 | 287,902 | 0 | 0 | Against |
| DE Shaw | 186,568 | 0 | 0 | 0 | For |
| BlackRock | 164,809 | 0 | 0 | 0 | For |
| State Street | 66,718 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 31,262 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 30,236 | 0 | 0 | 0 | For |
| WATER ISLAND CAPITAL LLC | 28,000 | 0 | 0 | 0 | For |
| Gabelli | 24,400 | 0 | 0 | 0 | For |
| Renaissance | 20,970 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 16,610 | 0 | 0 | Against |
| Vanguard | 15,267 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 14,000 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 13,000 | 0 | 0 | 0 | For |
| Baird | 12,000 | 0 | 0 | 0 | For |
| Northern Trust | 9,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,205 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Two Sigma | 4,550 | 0 | 0 | 0 | For |
| PALISADE CAPITAL MANAGEMENT, LP | 2,760 | 0 | 0 | 0 | For |
| WIMMER ASSOCIATES 1, LLC | 0 | 2,000 | 0 | 0 | Against |
| John Hancock | 1,030 | 0 | 0 | 0 | For |
Institutional-manager reports, all 47 managers: 4,260,938 for, 322,735 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held July 6, 2023.
Combines 2 wordings of this item as funds reported it.
— Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO CONSIDER AN ADVISORY VOTE ON THE FREQUENCY OF HOLDING FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 0 | 2,156,000 | 0 | Abstain |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| GENERAL AMERICAN INVESTORS CO INC | 0 | 0 | 0 | 0 | -- |
| BRUCE FUND INC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| NEXPOINT FUNDS II | 0 | 0 | 64,770 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 0 | 0 | 50,000 | 0 | Abstain |
| TETON WESTWOOD FUNDS | 0 | 0 | 0 | 0 | -- |
| World Funds Trust | 0 | 0 | 0 | 0 | -- |
| Gabelli | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Amplify ETF Trust | 0 | 0 | 0 | 0 | -- |
| HC CAPITAL TRUST | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| AltShares Trust | 0 | 0 | 0 | 0 | -- |
| NEXPOINT FUNDS I | 0 | 0 | 1,000 | 0 | Abstain |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Guggenheim | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 24 managers: 2,271,770 abstained, 5,780,227 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 0 | 0 | 0 | 0 | -- |
| J. Goldman & Co LP | 0 | 0 | 0 | 0 | -- |
| BROWN BROTHERS HARRIMAN & CO | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| WATER ISLAND CAPITAL LLC | 0 | 0 | 0 | 0 | -- |
| Gabelli | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| Baird | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| PALISADE CAPITAL MANAGEMENT, LP | 0 | 0 | 0 | 0 | -- |
| WIMMER ASSOCIATES 1, LLC | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| MANUFACTURERS & TRADERS TRUST CO | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 45 managers: 3,198,117 1 year, 31,262 3 year, 100 2 year. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held July 6, 2023.
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023.
PARATEK PHARMACEUTICALS INC.’s own tally for this item (“6. Ratification of Selection of Independent Registered Public Accounting Firm”): 38,200,538 for, 972,021 against — passed, per its Form 8-K filed July 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 6 – Ratification of Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 24 asset managers below reported 8,051,997 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HIGHLAND GLOBAL ALLOCATION FUND | 2,156,000 | 0 | 0 | 0 | For |
| Vanguard | 1,914,324 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 1,839,424 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 1,427,412 | 0 | 0 | 0 | For |
| BlackRock | 342,648 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS II | 64,770 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 61,000 | 0 | 0 | 0 | For |
| NEXPOINT REAL ESTATE STRATEGIES FUND | 50,000 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 33,000 | 0 | 0 | 0 | For |
| World Funds Trust | 32,000 | 0 | 0 | 0 | For |
| Gabelli | 31,000 | 0 | 0 | 0 | For |
| Fidelity | 20,673 | 0 | 0 | 0 | For |
| Charles Schwab | 17,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 17,271 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 15,971 | 0 | 0 | 0 | For |
| Northern Trust | 13,493 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,000 | 0 | 0 | 0 | For |
| Victory Capital | 5,001 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| AltShares Trust | 1,000 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 1,000 | 0 | 0 | 0 | For |
| John Hancock | 901 | 0 | 0 | 0 | For |
| Guggenheim | 285 | 0 | 0 | 0 | For |
| Invesco | 167 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,282,239 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | HIGHLAND GLOBAL ALLOCATION FUND | 3.76% |
| 2 | Vanguard | 3.34% |
| 3 | GENERAL AMERICAN INVESTORS CO INC | 3.21% |
| 4 | BRUCE FUND INC | 2.49% |
| 5 | BlackRock | 0.60% |
| 6 | NEXPOINT FUNDS II | 0.11% |
| 7 | BRIDGEWAY FUNDS INC | 0.11% |
| 8 | NEXPOINT REAL ESTATE STRATEGIES FUND | 0.09% |
| 9 | TETON WESTWOOD FUNDS | 0.06% |
| 10 | World Funds Trust | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Rock Springs Capital Management LP | 3.03% |
| 2 | BlackRock | 1.12% |
| 3 | Polar Asset Management Partners Inc. | 1.07% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.75% |
| 5 | Verition Fund Management LLC | 0.74% |
| 6 | Two Sigma | 0.64% |
| 7 | Newtyn Management, LLC | 0.60% |
| 8 | BROWN BROTHERS HARRIMAN & CO | 0.50% |
| 9 | DE Shaw | 0.43% |
| 10 | State Street | 0.23% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities Affiliated with NexPoint Advisors, L.P. | 11.68% | DEF14A |
| Evan Loh, M.D. | 2.01% | DEF14A |
| Adam Woodrow | 0.98% | DEF14A |
| Michael F. Bigham | 0.95% | DEF14A |
| Rolf K. Hoffmann | 0.11% | DEF14A |
| Kristine Peterson | 0.10% | DEF14A |
| Timothy R. Franson, M.D. | 0.10% | DEF14A |
| Jeffrey Stein, Ph.D. | 0.10% | DEF14A |
| Robert S. Radie | 0.09% | DEF14A |
| Thomas J. Dietz, Ph.D. | 0.09% | DEF14A |
Percentages above are of 57,282,239 shares outstanding, as reported by PARATEK PHARMACEUTICALS INC. on its Form 10-Q dated April 30, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PARATEK PHARMACEUTICALS INC.’s 10-Q dated April 30, 2023. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
PARATEK PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page).
proxyvotesnow.com, “PARATEK PHARMACEUTICALS INC. 2023 Annual & Special Meetings (2023-2024 season)”, https://proxyvotesnow.com/company/paratek-pharmaceuticals-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.